Intravenous Bisphosphonates for Postmenopausal Osteoporosis: Safety Profiles of Zoledronic Acid and Ibandronate in Clinical Practice

No Effect of Rosuvastatin in the Zoledronate-Induced Acute-Phase Response

(2011) Polyzois Makras et al.   CALCIFIED TISSUE INTERNATIONAL

Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis

(2011) René Rizzoli et al.   CALCIFIED TISSUE INTERNATIONAL

Antiresorptive therapies for osteoporosis: a clinical overview

(2011) Jian Sheng Chen et al.   Nature Reviews Endocrinology

Bisphosphonates for post-menopausal osteoporosis: are they all the same?

(2011) R. Rizzoli   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women

(2010) Keith Thompson et al.   BONE

Adverse Effects of Bisphosphonates

(2010) Bo Abrahamsen   CALCIFIED TISSUE INTERNATIONAL

Long-Term Use of Bisphosphonates in Osteoporosis

(2010) Nelson B. Watts et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older

(2010) Steven Boonen et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Treatment of postmenopausal osteoporosis, patient perspectives – focus on once yearly zoledronic acid

(2010) Raj Carmona   Patient Preference and Adherence

Safety of Bisphosphonates in the Treatment of Osteoporosis

(2009) Robert R. Recker et al.   AMERICAN JOURNAL OF MEDICINE

Osteoporosis treatments and adverse events

(2009) Daniel H Solomon et al.   CURRENT OPINION IN RHEUMATOLOGY

Atorvastatin May Have No Effect on Acute Phase Reaction in Children After Intravenous Bisphosphonate Infusion

(2008) Tarak Srivastava et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women

(2008) K. Lippuner et al.   OSTEOPOROSIS INTERNATIONAL